Kim KH - Search Results

1

Discovery and development of anti-HBV agents and their resistance.

Kim KH, Kim ND, Seong BL. Kim KH, et al. Among authors: kim nd. Molecules. 2010 Aug 27;15(9):5878-908. doi: 10.3390/molecules15095878. Molecules. 2010. PMID: 20802402 Free PMC article. Review.

2

Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin.

Kim DY, Kim KH, Kim ND, Lee KY, Han CK, Yoon JH, Moon SK, Lee SS, Seong BL. Kim DY, et al. Among authors: kim nd, kim kh. J Med Chem. 2006 Sep 21;49(19):5664-70. doi: 10.1021/jm050761i. J Med Chem. 2006. PMID: 16970393

3

Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation.

Ryu K, Kim ND, Choi SI, Han CK, Yoon JH, No KT, Kim KH, Seong BL. Ryu K, et al. Among authors: kim nd, kim kh. Bioorg Med Chem. 2009 Apr 15;17(8):2975-82. doi: 10.1016/j.bmc.2009.03.024. Epub 2009 Mar 18. Bioorg Med Chem. 2009. PMID: 19332375

4

Clinical and virological responses to clevudine therapy in chronic hepatitis B patients: results at 1 year of an open-labelled prospective study.

Ko SY, Kwon SY, Choe WH, Kim BK, Kim KH, Lee CH. Ko SY, et al. Among authors: kim bk, kim kh. Antivir Ther. 2009;14(4):585-90. Antivir Ther. 2009. PMID: 19578244 Clinical Trial.

5

Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir.

Choe WH, Hong SP, Kim BK, Ko SY, Jung YK, Kim JH, Yeon JE, Byun KS, Kim KH, Ji SI, Kim SO, Lee CH, Kwon SY. Choe WH, et al. Among authors: kim bk, kim so, kim kh, kim jh. Antivir Ther. 2009;14(7):985-93. doi: 10.3851/IMP1417. Antivir Ther. 2009. PMID: 19918102

6

Identification and characterization of clevudine-resistant mutants of hepatitis B virus isolated from chronic hepatitis B patients.

Kwon SY, Park YK, Ahn SH, Cho ES, Choe WH, Lee CH, Kim BK, Ko SY, Choi HS, Park ES, Shin GC, Kim KH. Kwon SY, et al. Among authors: kim bk, kim kh. J Virol. 2010 May;84(9):4494-503. doi: 10.1128/JVI.02066-09. Epub 2010 Feb 17. J Virol. 2010. PMID: 20164224 Free PMC article.

7

Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.

Kim ND, Park ES, Kim YH, Moon SK, Lee SS, Ahn SK, Yu DY, No KT, Kim KH. Kim ND, et al. Among authors: kim yh, kim kh. Bioorg Med Chem. 2010 Oct 1;18(19):7092-100. doi: 10.1016/j.bmc.2010.07.072. Epub 2010 Aug 6. Bioorg Med Chem. 2010. PMID: 20810285

8

Pharmacophore-based virtual screening: a review of recent applications.

Kim KH, Kim ND, Seong BL. Kim KH, et al. Among authors: kim nd. Expert Opin Drug Discov. 2010 Mar;5(3):205-22. doi: 10.1517/17460441003592072. Epub 2010 Jan 27. Expert Opin Drug Discov. 2010. PMID: 22823018

9

The impact of the hepatitis B virus polymerase rtA181T mutation on replication and drug resistance is potentially affected by overlapping changes in surface gene.

Ahn SH, Park YK, Park ES, Kim JH, Kim DH, Lim KH, Jang MS, Choe WH, Ko SY, Sung IK, Kwon SY, Kim KH. Ahn SH, et al. Among authors: kim dh, kim kh, kim jh. J Virol. 2014 Jun;88(12):6805-18. doi: 10.1128/JVI.00635-14. Epub 2014 Apr 2. J Virol. 2014. PMID: 24696492 Free PMC article.

10

Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy.

Chon YE, Jin B, Ahn SH, Kim S, Kim ND, Park JH, Nam CM, Kim KH, Hong SP, Choi SH, Kim DY, Park JY, Han KH. Chon YE, et al. Among authors: kim dy, kim s, kim nd, kim kh. Liver Int. 2015 Nov;35(11):2370-83. doi: 10.1111/liv.12845. Epub 2015 May 13. Liver Int. 2015. PMID: 25872678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,496 results

Search Page

Filters